Pei‐Fen Chen
Impact in
- Geriatrics and Gerontology top 5%
- Sirtuins and Resveratrol in Medicine
-
- Antiplatelet Therapy and Cardiovascular Diseases
Papers in
-
- Antiplatelet Therapy and Cardiovascular Diseases 3
- Co-authors
- Yi‐Wen Tsai (11 shared papers)I‐Chieh Chen (4 shared papers)Hung‐Che Chiang (4 shared papers)Wei‐Fan Chiang (3 shared papers)Weng-Foung Huang (6 shared papers)Fei‐Yuan Hsiao (6 shared papers)Yu-Wen Wen (5 shared papers)Yubiao Guo (1 shared paper)
- Journals
- Pharmacoepidemiology and Drug Safety (3 papers)Molecular Cancer (2 papers)Foods (2 papers)Journal of Proteome Research (1 paper)Emerging Microbes & Infections (1 paper)
- Partner nations
- TaiwanChinaUnited States
In The Last Decade
Pei‐Fen Chen
46 papers receiving 778 citations
Peers
Comparison fields: 5 of 125
- Geriatrics and Gerontology 72
- Cardiology and Cardiovascular Medicine 105
- Critical Care and Intensive Care Medicine 21
- Immunology 88
- Gastroenterology 20
Countries citing papers authored by Pei‐Fen Chen
This map shows the geographic impact of Pei‐Fen Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pei‐Fen Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pei‐Fen Chen more than expected).
Fields of papers citing papers by Pei‐Fen Chen
This network shows the impact of papers produced by Pei‐Fen Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pei‐Fen Chen. The network helps show where Pei‐Fen Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Pei‐Fen Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 49 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 103 | |
| 2 | 2014 | 84 | |
| 3 | 2010 | 46 | |
| 4 | 2005 | 39 | |
| 5 | 2009 | 35 | |
| 6 | 2013 | 34 | |
| 7 | 2009 | 30 | |
| 8 | 2011 | 27 | |
| 9 | 2010 | 27 | |
| 10 | 2013 | 26 | |
| 11 | 2022 | 25 | |
| 12 | 2022 | 23 | |
| 13 | 2022 | 23 | |
| 14 | 2011 | 19 | |
| 15 | 2022 | 19 | |
| 16 | 2013 | 17 | |
| 17 | 2020 | 16 | |
| 18 | 2013 | 15 | |
| 19 | 2011 | 15 | |
| 20 | 2007 | 14 |
About Pei‐Fen Chen
Pei‐Fen Chen is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine, Pathology and Forensic Medicine, Geriatrics and Gerontology and Pulmonary and Respiratory Medicine, having authored 49 papers that have together received 793 indexed citations. Recurring topics across this work include Sirtuins and Resveratrol in Medicine (4 papers), Tea Polyphenols and Effects (4 papers), Antiplatelet Therapy and Cardiovascular Diseases (3 papers), Health Systems, Economic Evaluations, Quality of Life (2 papers), Smoking Behavior and Cessation (2 papers), Air Quality and Health Impacts (2 papers), Antibiotic Resistance in Bacteria (2 papers) and Food Quality and Safety Studies (2 papers). The work is most often cited by research in Geriatrics and Gerontology (72 citations), Cardiology and Cardiovascular Medicine (105 citations), Critical Care and Intensive Care Medicine (21 citations), Immunology (88 citations) and Gastroenterology (20 citations). Pei‐Fen Chen has collaborated with scholars based in Taiwan, China and United States. Frequent co-authors include Yi‐Wen Tsai, I‐Chieh Chen, Hung‐Che Chiang, Wei‐Fan Chiang, Weng-Foung Huang, Fei‐Yuan Hsiao, Yu-Wen Wen, Yubiao Guo, Xinyan Huang and Weiping Tan. Their work appears in journals such as Pharmacoepidemiology and Drug Safety, Molecular Cancer, Foods, Journal of Proteome Research and Emerging Microbes & Infections.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.